Expression and Interactions Between Cell Adhesion Molecules CD44v6 and E-Cadherin in Human Gliomas.

BACKGROUND: Gliomas are a heterogenous group of tumors that show the same histological features but differ in their behavior. Gliomas are characterized by biological aggressiveness and extensive infiltrative growth into surrounding healthy brain tissue. OBJECTIVES: In this study we estimated CD44v6 and E-cadherin expression and correlation between CD44v6 and E-cadherin in relation to glioma malignancy. We also analyzed simultaneous expression of CD44v6 and E-cadherin in the same tumor sample in order to determine the biological tumor behavior. MATERIAL AND METHODS: Expression of CD44v6 and E-cadherin was evaluated on ninety-two formalin-fixed paraffin-embedded glioma tissue blocks using immunohistochemistry (IHC). RESULTS: CD44v6 expression was found in 71.6% of gliomas. There was a statistically significant difference between the frequency of positive cases for CD44v6 expression in low (grade I) vs. high (grade IV) as well as in grade I vs. grade II of glioma malignancy (p = 0.001). E-cadherin membrane staining was observed in 28.8% of gliomas. No significant differences were observed between E-cadherin expression and grade of gliomas (p > 0.05). However, re-expression of E-cadherin was found in grade II gliomas. In this group, E-cadherin expression was revealed in 43.3% of the cases. In order to define the relationship between CD44v6 expression and E-cadherin, we analyzed the simultaneous expression of CD44v6 and E-cadherin in the same glioma sample in the whole group and in respect to the degree of glioma malignancy. A positive correlation between studied biomarkers was observed in the analyzed gliomas (p = 0.004) but a simultaneous expression of CD44v6 and E-cadherin revealed no significant differences in respect to glioma malignancy. CONCLUSIONS: Our results showed that the level of E-cadherin might reflect different biological features of gliomas, whereas CD44v6 is associated with tumor cell malignancy. The simultaneous presence of CD44v6 and E-cadherin in a set of low-grade gliomas indicates that both these molecules might strengthen cell migration and may be a hallmark of glioma invasive growth.

[Rare clinical form of glioblastoma multiforme]. / Rzadkie kliniczne odmiany glejaka wielopostaciowego.

Glioblastoma multiforme (glioblastoma multiforme - GBM) is the most malignant tumor classified by WHO. It is also the most common primary CNS tumor with a very aggressive course and unfavourable prognosis, usually develops in adults, and is typically located supratentorially in the fronto-temporal region. However, the literature describes an unusual position of GBM (e.g. spinal cord, pons, pineal region), familial gliomas unconnected with the family of gliomas predisposed to the occurrence of syndromes, unusual glioma and metastatic sites, gliomas transplanted with organs. In this paper, based on the available literature, the authors discuss an unusual and rare form of glioblastoma multiforme.

Evaluation of pain in patients with lumbar disc surgery using VAS scale and quantitative sensory testing.

BACKGROUND: Pain is interpreted at the cortex level, however, pain signaling stimuli arise at the periphery and are conveyed by nociceptive A delta and C fibers. OBJECTIVES: Evaluation of pain using the VAS scale in pre- and postoperative S1 sciatica patients with regard to thermal thresholds in the corresponding dermatome. MATERIAL AND METHODS: Twenty-six S1 sciatica patients with herniated disc on an MRI, non-responsive to conservative care, were involved in the study. Pain in the affected leg was measured using the VAS scale and thermal thresholds in S1 symptomatic dermatome using Quantitative Sensory Testing (QST). RESULTS: Pain intensity as well as thermal thresholds were increased in sciatica patients compared to controls. Disc surgery resulted in a pronounced lowering of pain in each of the operated patients. From the whole group, 21 subjects were examined postoperatively six months later. In the group with complete clinical recovery, thermal thresholds were within normal limits. In those patients with residual pain disability, normalization of thresholds has not been achieved. CONCLUSIONS: Pain in sciatica patients may be objectively measured by QST.